nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Leflunomide—systemic lupus erythematosus	0.084	0.117	CbGbCtD
Toremifene—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0599	0.0834	CbGbCtD
Toremifene—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.058	0.0807	CbGbCtD
Toremifene—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0454	0.0632	CbGbCtD
Toremifene—ABCB1—Betamethasone—systemic lupus erythematosus	0.0389	0.0542	CbGbCtD
Toremifene—ABCB1—Prednisolone—systemic lupus erythematosus	0.0384	0.0535	CbGbCtD
Toremifene—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0364	0.0507	CbGbCtD
Toremifene—ABCB1—Prednisone—systemic lupus erythematosus	0.0363	0.0505	CbGbCtD
Toremifene—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0359	0.05	CbGbCtD
Toremifene—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0344	0.0479	CbGbCtD
Toremifene—CYP3A4—Dapsone—systemic lupus erythematosus	0.0314	0.0437	CbGbCtD
Toremifene—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0272	0.0379	CbGbCtD
Toremifene—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0272	0.0379	CbGbCtD
Toremifene—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0233	0.0325	CbGbCtD
Toremifene—CYP3A4—Prednisolone—systemic lupus erythematosus	0.023	0.032	CbGbCtD
Toremifene—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0227	0.0315	CbGbCtD
Toremifene—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0218	0.0304	CbGbCtD
Toremifene—CYP3A4—Prednisone—systemic lupus erythematosus	0.0217	0.0303	CbGbCtD
Toremifene—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0206	0.0287	CbGbCtD
Toremifene—ABCB1—Methotrexate—systemic lupus erythematosus	0.0182	0.0253	CbGbCtD
Toremifene—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0136	0.0189	CbGbCtD
Toremifene—CYP1A2—urine—systemic lupus erythematosus	0.00134	0.148	CbGeAlD
Toremifene—CYP3A4—urine—systemic lupus erythematosus	0.000973	0.107	CbGeAlD
Toremifene—CYP1A2—blood plasma—systemic lupus erythematosus	0.000701	0.0772	CbGeAlD
Toremifene—CYP3A4—blood plasma—systemic lupus erythematosus	0.000508	0.0559	CbGeAlD
Toremifene—ESR1—connective tissue—systemic lupus erythematosus	0.000484	0.0533	CbGeAlD
Toremifene—ESR1—kidney—systemic lupus erythematosus	0.000412	0.0454	CbGeAlD
Toremifene—Eye disorder—Methylprednisolone—systemic lupus erythematosus	0.000385	0.00151	CcSEcCtD
Toremifene—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000384	0.0015	CcSEcCtD
Toremifene—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000384	0.0015	CcSEcCtD
Toremifene—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000382	0.00149	CcSEcCtD
Toremifene—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000376	0.00147	CcSEcCtD
Toremifene—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000375	0.00147	CcSEcCtD
Toremifene—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000374	0.00146	CcSEcCtD
Toremifene—Mood swings—Methotrexate—systemic lupus erythematosus	0.000373	0.00146	CcSEcCtD
Toremifene—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.000371	0.00145	CcSEcCtD
Toremifene—Weight increased—Prednisone—systemic lupus erythematosus	0.000371	0.00145	CcSEcCtD
Toremifene—Ataxia—Methotrexate—systemic lupus erythematosus	0.00037	0.00145	CcSEcCtD
Toremifene—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.000369	0.00144	CcSEcCtD
Toremifene—Vision blurred—Prednisolone—systemic lupus erythematosus	0.000368	0.00144	CcSEcCtD
Toremifene—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.000368	0.00144	CcSEcCtD
Toremifene—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000366	0.00143	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	0.000364	0.00142	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000363	0.00142	CcSEcCtD
Toremifene—Visual impairment—Betamethasone—systemic lupus erythematosus	0.000361	0.00141	CcSEcCtD
Toremifene—Visual impairment—Dexamethasone—systemic lupus erythematosus	0.000361	0.00141	CcSEcCtD
Toremifene—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.000361	0.00141	CcSEcCtD
Toremifene—ABCB1—blood plasma—systemic lupus erythematosus	0.000359	0.0396	CbGeAlD
Toremifene—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000358	0.0014	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.000358	0.0014	CcSEcCtD
Toremifene—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000357	0.00139	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—systemic lupus erythematosus	0.000356	0.00139	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—systemic lupus erythematosus	0.000356	0.00139	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—systemic lupus erythematosus	0.000356	0.00139	CcSEcCtD
Toremifene—ESR1—lymphoid tissue—systemic lupus erythematosus	0.000354	0.039	CbGeAlD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000354	0.00139	CcSEcCtD
Toremifene—Vertigo—Prednisolone—systemic lupus erythematosus	0.000351	0.00137	CcSEcCtD
Toremifene—Oedema—Cyclosporine—systemic lupus erythematosus	0.00035	0.00137	CcSEcCtD
Toremifene—Eye disorder—Betamethasone—systemic lupus erythematosus	0.00035	0.00137	CcSEcCtD
Toremifene—Eye disorder—Dexamethasone—systemic lupus erythematosus	0.00035	0.00137	CcSEcCtD
Toremifene—Back pain—Triamcinolone—systemic lupus erythematosus	0.000348	0.00136	CcSEcCtD
Toremifene—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000344	0.00134	CcSEcCtD
Toremifene—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000343	0.00134	CcSEcCtD
Toremifene—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000343	0.00134	CcSEcCtD
Toremifene—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000342	0.00134	CcSEcCtD
Toremifene—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00034	0.00133	CcSEcCtD
Toremifene—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00034	0.00133	CcSEcCtD
Toremifene—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00034	0.00133	CcSEcCtD
Toremifene—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000339	0.00133	CcSEcCtD
Toremifene—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000335	0.00131	CcSEcCtD
Toremifene—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000335	0.00131	CcSEcCtD
Toremifene—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000335	0.00131	CcSEcCtD
Toremifene—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000335	0.00131	CcSEcCtD
Toremifene—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000334	0.00131	CcSEcCtD
Toremifene—CYP1A1—skin of body—systemic lupus erythematosus	0.000333	0.0366	CbGeAlD
Toremifene—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000332	0.0013	CcSEcCtD
Toremifene—Alopecia—Betamethasone—systemic lupus erythematosus	0.000331	0.00129	CcSEcCtD
Toremifene—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000331	0.00129	CcSEcCtD
Toremifene—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.00033	0.00129	CcSEcCtD
Toremifene—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000326	0.00127	CcSEcCtD
Toremifene—Asthenia—Leflunomide—systemic lupus erythematosus	0.000326	0.00127	CcSEcCtD
Toremifene—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000323	0.00126	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000323	0.00126	CcSEcCtD
Toremifene—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000322	0.00126	CcSEcCtD
Toremifene—Pruritus—Leflunomide—systemic lupus erythematosus	0.000321	0.00126	CcSEcCtD
Toremifene—Oedema—Prednisolone—systemic lupus erythematosus	0.000319	0.00125	CcSEcCtD
Toremifene—Dizziness—Azathioprine—systemic lupus erythematosus	0.000318	0.00124	CcSEcCtD
Toremifene—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000317	0.00124	CcSEcCtD
Toremifene—CYP1A1—kidney—systemic lupus erythematosus	0.000314	0.0345	CbGeAlD
Toremifene—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000312	0.00122	CcSEcCtD
Toremifene—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000311	0.00122	CcSEcCtD
Toremifene—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000309	0.00121	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000308	0.00121	CcSEcCtD
Toremifene—Vomiting—Azathioprine—systemic lupus erythematosus	0.000306	0.0012	CcSEcCtD
Toremifene—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000305	0.00119	CcSEcCtD
Toremifene—Eye disorder—Prednisone—systemic lupus erythematosus	0.000305	0.00119	CcSEcCtD
Toremifene—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000305	0.00119	CcSEcCtD
Toremifene—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000305	0.00119	CcSEcCtD
Toremifene—Rash—Azathioprine—systemic lupus erythematosus	0.000303	0.00119	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000303	0.00119	CcSEcCtD
Toremifene—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000303	0.00118	CcSEcCtD
Toremifene—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000303	0.00118	CcSEcCtD
Toremifene—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000302	0.00118	CcSEcCtD
Toremifene—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000302	0.00118	CcSEcCtD
Toremifene—Headache—Azathioprine—systemic lupus erythematosus	0.000301	0.00118	CcSEcCtD
Toremifene—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000301	0.00118	CcSEcCtD
Toremifene—Dizziness—Leflunomide—systemic lupus erythematosus	0.0003	0.00117	CcSEcCtD
Toremifene—Constipation—Cyclosporine—systemic lupus erythematosus	0.0003	0.00117	CcSEcCtD
Toremifene—Pain—Cyclosporine—systemic lupus erythematosus	0.0003	0.00117	CcSEcCtD
Toremifene—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000297	0.00116	CcSEcCtD
Toremifene—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000297	0.00116	CcSEcCtD
Toremifene—Angiopathy—Prednisone—systemic lupus erythematosus	0.000296	0.00116	CcSEcCtD
Toremifene—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000295	0.00115	CcSEcCtD
Toremifene—Oedema—Triamcinolone—systemic lupus erythematosus	0.000293	0.00115	CcSEcCtD
Toremifene—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000293	0.00115	CcSEcCtD
Toremifene—Vertigo—Betamethasone—systemic lupus erythematosus	0.000293	0.00115	CcSEcCtD
Toremifene—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000292	0.00114	CcSEcCtD
Toremifene—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000292	0.00114	CcSEcCtD
Toremifene—ESR1—lung—systemic lupus erythematosus	0.000292	0.0322	CbGeAlD
Toremifene—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000291	0.00114	CcSEcCtD
Toremifene—Sweating—Methotrexate—systemic lupus erythematosus	0.000291	0.00114	CcSEcCtD
Toremifene—Vomiting—Leflunomide—systemic lupus erythematosus	0.000289	0.00113	CcSEcCtD
Toremifene—Insomnia—Prednisolone—systemic lupus erythematosus	0.000288	0.00113	CcSEcCtD
Toremifene—Alopecia—Prednisone—systemic lupus erythematosus	0.000288	0.00113	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000287	0.00112	CcSEcCtD
Toremifene—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000287	0.00112	CcSEcCtD
Toremifene—Rash—Leflunomide—systemic lupus erythematosus	0.000286	0.00112	CcSEcCtD
Toremifene—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000286	0.00112	CcSEcCtD
Toremifene—Mental disorder—Prednisone—systemic lupus erythematosus	0.000286	0.00112	CcSEcCtD
Toremifene—Nausea—Azathioprine—systemic lupus erythematosus	0.000286	0.00112	CcSEcCtD
Toremifene—Headache—Leflunomide—systemic lupus erythematosus	0.000284	0.00111	CcSEcCtD
Toremifene—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000284	0.00111	CcSEcCtD
Toremifene—Malnutrition—Prednisone—systemic lupus erythematosus	0.000284	0.00111	CcSEcCtD
Toremifene—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000283	0.00111	CcSEcCtD
Toremifene—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000283	0.00111	CcSEcCtD
Toremifene—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000282	0.0011	CcSEcCtD
Toremifene—Pain—Prednisolone—systemic lupus erythematosus	0.000273	0.00107	CcSEcCtD
Toremifene—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000271	0.00106	CcSEcCtD
Toremifene—ESR1—nervous system—systemic lupus erythematosus	0.000271	0.0298	CbGeAlD
Toremifene—Nausea—Leflunomide—systemic lupus erythematosus	0.00027	0.00106	CcSEcCtD
Toremifene—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000269	0.00105	CcSEcCtD
Toremifene—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000268	0.00105	CcSEcCtD
Toremifene—Vision blurred—Prednisone—systemic lupus erythematosus	0.000268	0.00105	CcSEcCtD
Toremifene—Pain—Hydrocortisone—systemic lupus erythematosus	0.000266	0.00104	CcSEcCtD
Toremifene—Oedema—Dexamethasone—systemic lupus erythematosus	0.000266	0.00104	CcSEcCtD
Toremifene—Oedema—Betamethasone—systemic lupus erythematosus	0.000266	0.00104	CcSEcCtD
Toremifene—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000265	0.00104	CcSEcCtD
Toremifene—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000265	0.00104	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000263	0.00103	CcSEcCtD
Toremifene—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000261	0.00102	CcSEcCtD
Toremifene—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000261	0.00102	CcSEcCtD
Toremifene—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000261	0.00102	CcSEcCtD
Toremifene—ESR1—central nervous system—systemic lupus erythematosus	0.000261	0.0287	CbGeAlD
Toremifene—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.00026	0.00102	CcSEcCtD
Toremifene—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.00026	0.00102	CcSEcCtD
Toremifene—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000257	0.00101	CcSEcCtD
Toremifene—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000257	0.00101	CcSEcCtD
Toremifene—Vertigo—Prednisone—systemic lupus erythematosus	0.000255	0.000998	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000255	0.000996	CcSEcCtD
Toremifene—Anorexia—Betamethasone—systemic lupus erythematosus	0.000254	0.000992	CcSEcCtD
Toremifene—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000254	0.000992	CcSEcCtD
Toremifene—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000253	0.000989	CcSEcCtD
Toremifene—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000252	0.000987	CcSEcCtD
Toremifene—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000251	0.000983	CcSEcCtD
Toremifene—Pain—Triamcinolone—systemic lupus erythematosus	0.000251	0.000981	CcSEcCtD
Toremifene—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000248	0.00097	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000247	0.000967	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000246	0.000961	CcSEcCtD
Toremifene—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.000959	CcSEcCtD
Toremifene—Chills—Methotrexate—systemic lupus erythematosus	0.000245	0.000957	CcSEcCtD
Toremifene—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000242	0.000946	CcSEcCtD
Toremifene—Alopecia—Methotrexate—systemic lupus erythematosus	0.000241	0.000942	CcSEcCtD
Toremifene—Insomnia—Betamethasone—systemic lupus erythematosus	0.000241	0.000941	CcSEcCtD
Toremifene—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000241	0.000941	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.00024	0.000939	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000239	0.000934	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000237	0.000928	CcSEcCtD
Toremifene—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000232	0.000906	CcSEcCtD
Toremifene—Oedema—Prednisone—systemic lupus erythematosus	0.000232	0.000906	CcSEcCtD
Toremifene—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000231	0.000905	CcSEcCtD
Toremifene—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000231	0.000905	CcSEcCtD
Toremifene—CYP3A4—kidney—systemic lupus erythematosus	0.00023	0.0253	CbGeAlD
Toremifene—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00023	0.000899	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00023	0.000899	CcSEcCtD
Toremifene—Back pain—Methotrexate—systemic lupus erythematosus	0.000229	0.000898	CcSEcCtD
Toremifene—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000229	0.000897	CcSEcCtD
Toremifene—Fatigue—Betamethasone—systemic lupus erythematosus	0.000229	0.000897	CcSEcCtD
Toremifene—Pain—Betamethasone—systemic lupus erythematosus	0.000228	0.00089	CcSEcCtD
Toremifene—Pain—Dexamethasone—systemic lupus erythematosus	0.000228	0.00089	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000227	0.000889	CcSEcCtD
Toremifene—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.000884	CcSEcCtD
Toremifene—CYP1A2—lung—systemic lupus erythematosus	0.000225	0.0248	CbGeAlD
Toremifene—Skin disorder—Prednisone—systemic lupus erythematosus	0.000225	0.00088	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000224	0.000876	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000224	0.000875	CcSEcCtD
Toremifene—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000223	0.000874	CcSEcCtD
Toremifene—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000223	0.000872	CcSEcCtD
Toremifene—CYP1A1—lung—systemic lupus erythematosus	0.000222	0.0245	CbGeAlD
Toremifene—Rash—Cyclosporine—systemic lupus erythematosus	0.000221	0.000864	CcSEcCtD
Toremifene—Anorexia—Prednisone—systemic lupus erythematosus	0.000221	0.000864	CcSEcCtD
Toremifene—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000221	0.000863	CcSEcCtD
Toremifene—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.00022	0.000862	CcSEcCtD
Toremifene—Headache—Cyclosporine—systemic lupus erythematosus	0.00022	0.000859	CcSEcCtD
Toremifene—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000217	0.00085	CcSEcCtD
Toremifene—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000216	0.000843	CcSEcCtD
Toremifene—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000215	0.000842	CcSEcCtD
Toremifene—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.000838	CcSEcCtD
Toremifene—Vertigo—Methotrexate—systemic lupus erythematosus	0.000213	0.000834	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000212	0.000831	CcSEcCtD
Toremifene—Dizziness—Prednisolone—systemic lupus erythematosus	0.000211	0.000825	CcSEcCtD
Toremifene—Asthenia—Triamcinolone—systemic lupus erythematosus	0.00021	0.000823	CcSEcCtD
Toremifene—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.00021	0.000821	CcSEcCtD
Toremifene—Insomnia—Prednisone—systemic lupus erythematosus	0.00021	0.00082	CcSEcCtD
Toremifene—Nausea—Cyclosporine—systemic lupus erythematosus	0.000208	0.000814	CcSEcCtD
Toremifene—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000207	0.000812	CcSEcCtD
Toremifene—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000207	0.00081	CcSEcCtD
Toremifene—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000206	0.000806	CcSEcCtD
Toremifene—CYP1A1—nervous system—systemic lupus erythematosus	0.000206	0.0227	CbGeAlD
Toremifene—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000203	0.000794	CcSEcCtD
Toremifene—Chest pain—Methotrexate—systemic lupus erythematosus	0.000202	0.00079	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000201	0.000788	CcSEcCtD
Toremifene—Rash—Prednisolone—systemic lupus erythematosus	0.000201	0.000786	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000201	0.000786	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000201	0.000785	CcSEcCtD
Toremifene—Fatigue—Prednisone—systemic lupus erythematosus	0.0002	0.000781	CcSEcCtD
Toremifene—Headache—Prednisolone—systemic lupus erythematosus	0.0002	0.000781	CcSEcCtD
Toremifene—Constipation—Prednisone—systemic lupus erythematosus	0.000198	0.000775	CcSEcCtD
Toremifene—CYP1A1—central nervous system—systemic lupus erythematosus	0.000198	0.0218	CbGeAlD
Toremifene—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000198	0.000775	CcSEcCtD
Toremifene—Rash—Hydrocortisone—systemic lupus erythematosus	0.000196	0.000768	CcSEcCtD
Toremifene—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000196	0.000767	CcSEcCtD
Toremifene—Headache—Hydrocortisone—systemic lupus erythematosus	0.000195	0.000763	CcSEcCtD
Toremifene—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000194	0.000759	CcSEcCtD
Toremifene—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000193	0.000757	CcSEcCtD
Toremifene—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000191	0.000747	CcSEcCtD
Toremifene—Asthenia—Betamethasone—systemic lupus erythematosus	0.000191	0.000747	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.00019	0.000743	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.00019	0.000742	CcSEcCtD
Toremifene—Nausea—Prednisolone—systemic lupus erythematosus	0.000189	0.000741	CcSEcCtD
Toremifene—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000188	0.000736	CcSEcCtD
Toremifene—Pruritus—Betamethasone—systemic lupus erythematosus	0.000188	0.000736	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000188	0.000736	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000187	0.000732	CcSEcCtD
Toremifene—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000186	0.000729	CcSEcCtD
Toremifene—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000186	0.000728	CcSEcCtD
Toremifene—ABCB1—nephron tubule—systemic lupus erythematosus	0.000185	0.0204	CbGeAlD
Toremifene—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000185	0.000724	CcSEcCtD
Toremifene—Rash—Triamcinolone—systemic lupus erythematosus	0.000185	0.000723	CcSEcCtD
Toremifene—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000185	0.000723	CcSEcCtD
Toremifene—Anorexia—Methotrexate—systemic lupus erythematosus	0.000185	0.000722	CcSEcCtD
Toremifene—Rash—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000722	CcSEcCtD
Toremifene—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000721	CcSEcCtD
Toremifene—Headache—Triamcinolone—systemic lupus erythematosus	0.000184	0.000719	CcSEcCtD
Toremifene—Headache—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000717	CcSEcCtD
Toremifene—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000176	0.000688	CcSEcCtD
Toremifene—Dizziness—Betamethasone—systemic lupus erythematosus	0.000176	0.000688	CcSEcCtD
Toremifene—Insomnia—Methotrexate—systemic lupus erythematosus	0.000175	0.000685	CcSEcCtD
Toremifene—Nausea—Triamcinolone—systemic lupus erythematosus	0.000174	0.000681	CcSEcCtD
Toremifene—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000174	0.00068	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000173	0.000675	CcSEcCtD
Toremifene—Vomiting—Betamethasone—systemic lupus erythematosus	0.000169	0.000662	CcSEcCtD
Toremifene—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000169	0.000662	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000168	0.000659	CcSEcCtD
Toremifene—Rash—Betamethasone—systemic lupus erythematosus	0.000168	0.000656	CcSEcCtD
Toremifene—Rash—Dexamethasone—systemic lupus erythematosus	0.000168	0.000656	CcSEcCtD
Toremifene—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000168	0.000656	CcSEcCtD
Toremifene—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000168	0.000656	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000167	0.000654	CcSEcCtD
Toremifene—Fatigue—Methotrexate—systemic lupus erythematosus	0.000167	0.000653	CcSEcCtD
Toremifene—Headache—Dexamethasone—systemic lupus erythematosus	0.000167	0.000652	CcSEcCtD
Toremifene—Headache—Betamethasone—systemic lupus erythematosus	0.000167	0.000652	CcSEcCtD
Toremifene—Asthenia—Prednisone—systemic lupus erythematosus	0.000166	0.00065	CcSEcCtD
Toremifene—Pain—Methotrexate—systemic lupus erythematosus	0.000166	0.000648	CcSEcCtD
Toremifene—Pruritus—Prednisone—systemic lupus erythematosus	0.000164	0.000641	CcSEcCtD
Toremifene—ABCB1—kidney—systemic lupus erythematosus	0.000163	0.0179	CbGeAlD
Toremifene—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000159	0.0175	CbGeAlD
Toremifene—Nausea—Dexamethasone—systemic lupus erythematosus	0.000158	0.000618	CcSEcCtD
Toremifene—Nausea—Betamethasone—systemic lupus erythematosus	0.000158	0.000618	CcSEcCtD
Toremifene—Dizziness—Prednisone—systemic lupus erythematosus	0.000153	0.000599	CcSEcCtD
Toremifene—CYP3A4—nervous system—systemic lupus erythematosus	0.000151	0.0166	CbGeAlD
Toremifene—Vomiting—Prednisone—systemic lupus erythematosus	0.000147	0.000576	CcSEcCtD
Toremifene—Rash—Prednisone—systemic lupus erythematosus	0.000146	0.000572	CcSEcCtD
Toremifene—Dermatitis—Prednisone—systemic lupus erythematosus	0.000146	0.000571	CcSEcCtD
Toremifene—CYP3A4—central nervous system—systemic lupus erythematosus	0.000145	0.016	CbGeAlD
Toremifene—Headache—Prednisone—systemic lupus erythematosus	0.000145	0.000568	CcSEcCtD
Toremifene—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.00014	0.0154	CbGeAlD
Toremifene—Asthenia—Methotrexate—systemic lupus erythematosus	0.000139	0.000544	CcSEcCtD
Toremifene—Nausea—Prednisone—systemic lupus erythematosus	0.000138	0.000538	CcSEcCtD
Toremifene—Pruritus—Methotrexate—systemic lupus erythematosus	0.000137	0.000536	CcSEcCtD
Toremifene—Dizziness—Methotrexate—systemic lupus erythematosus	0.000128	0.000501	CcSEcCtD
Toremifene—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000128	0.0076	CbGpPWpGaD
Toremifene—ABCB1—bone marrow—systemic lupus erythematosus	0.000127	0.014	CbGeAlD
Toremifene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000127	0.00752	CbGpPWpGaD
Toremifene—Vomiting—Methotrexate—systemic lupus erythematosus	0.000123	0.000482	CcSEcCtD
Toremifene—Rash—Methotrexate—systemic lupus erythematosus	0.000122	0.000478	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000122	0.000477	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—IL10—systemic lupus erythematosus	0.000122	0.00723	CbGpPWpGaD
Toremifene—Headache—Methotrexate—systemic lupus erythematosus	0.000121	0.000475	CcSEcCtD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—systemic lupus erythematosus	0.00012	0.0071	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL4—systemic lupus erythematosus	0.000118	0.00704	CbGpPWpGaD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000118	0.00701	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000118	0.00699	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—C3—systemic lupus erythematosus	0.000116	0.00687	CbGpPWpGaD
Toremifene—ABCB1—lung—systemic lupus erythematosus	0.000115	0.0127	CbGeAlD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—NOS3—systemic lupus erythematosus	0.000115	0.00684	CbGpPWpGaD
Toremifene—Nausea—Methotrexate—systemic lupus erythematosus	0.000115	0.00045	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—NR3C1—systemic lupus erythematosus	0.000113	0.00669	CbGpPWpGaD
Toremifene—ESR1—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000112	0.00668	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	0.000111	0.00662	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—JAK1—systemic lupus erythematosus	0.00011	0.00653	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000109	0.00649	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000109	0.00645	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	0.000108	0.00644	CbGpPWpGaD
Toremifene—ABCB1—nervous system—systemic lupus erythematosus	0.000107	0.0118	CbGeAlD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000104	0.00615	CbGpPWpGaD
Toremifene—ABCB1—central nervous system—systemic lupus erythematosus	0.000103	0.0113	CbGeAlD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	0.0001	0.00596	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	9.84e-05	0.00585	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	9.61e-05	0.00571	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	9.43e-05	0.0056	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	9.42e-05	0.0056	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	9.32e-05	0.00554	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—systemic lupus erythematosus	9.24e-05	0.00549	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	9.1e-05	0.00541	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	9.04e-05	0.00537	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	8.91e-05	0.00529	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	8.67e-05	0.00515	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CXCL12—systemic lupus erythematosus	8.64e-05	0.00513	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	8.6e-05	0.00511	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—EP300—systemic lupus erythematosus	8.59e-05	0.0051	CbGpPWpGaD
Toremifene—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	8.43e-05	0.00501	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	8.42e-05	0.005	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.4e-05	0.00499	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	8.4e-05	0.00499	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	8.28e-05	0.00492	CbGpPWpGaD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.23e-05	0.00489	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IFNG—systemic lupus erythematosus	8.21e-05	0.00488	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	8e-05	0.00475	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	7.99e-05	0.00475	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—NAT2—systemic lupus erythematosus	7.96e-05	0.00473	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	7.85e-05	0.00466	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PRL—systemic lupus erythematosus	7.82e-05	0.00464	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	7.72e-05	0.00459	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	7.63e-05	0.00453	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	7.57e-05	0.0045	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	7.52e-05	0.00447	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	7.49e-05	0.00445	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IFNG—systemic lupus erythematosus	7.33e-05	0.00435	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	7.27e-05	0.00432	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	7.16e-05	0.00425	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—NOS3—systemic lupus erythematosus	7.1e-05	0.00422	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	7.07e-05	0.0042	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CDKN1B—systemic lupus erythematosus	6.66e-05	0.00395	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.64e-05	0.00394	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	6.62e-05	0.00393	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.6e-05	0.00392	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.57e-05	0.0039	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—EP300—systemic lupus erythematosus	6.55e-05	0.00389	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IL2—systemic lupus erythematosus	6.51e-05	0.00387	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	6.5e-05	0.00386	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	6.49e-05	0.00385	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—RXRA—systemic lupus erythematosus	6.38e-05	0.00379	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	6.36e-05	0.00378	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	6.36e-05	0.00378	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	6.28e-05	0.00373	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—JAK1—systemic lupus erythematosus	6.25e-05	0.00371	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	6.24e-05	0.00371	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	6.19e-05	0.00368	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	6.19e-05	0.00368	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	6.13e-05	0.00364	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	6.03e-05	0.00358	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.03e-05	0.00358	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	6.02e-05	0.00358	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.95e-05	0.00354	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	5.9e-05	0.0035	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	5.85e-05	0.00347	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	5.85e-05	0.00347	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	5.71e-05	0.00339	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	5.69e-05	0.00338	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.56e-05	0.0033	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	5.44e-05	0.00323	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.35e-05	0.00318	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	5.34e-05	0.00317	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	5.29e-05	0.00314	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.29e-05	0.00314	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	5.24e-05	0.00311	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	5.21e-05	0.0031	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	5.17e-05	0.00307	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.11e-05	0.00304	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.1e-05	0.00303	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SNRPD1—systemic lupus erythematosus	5.09e-05	0.00302	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	5.08e-05	0.00302	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—systemic lupus erythematosus	5.08e-05	0.00302	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	5.07e-05	0.00301	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	5.07e-05	0.00301	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.07e-05	0.00301	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.01e-05	0.00298	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5e-05	0.00297	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	4.96e-05	0.00295	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.89e-05	0.00291	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CD80—systemic lupus erythematosus	4.87e-05	0.00289	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	4.71e-05	0.0028	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.6e-05	0.00273	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MTA2—systemic lupus erythematosus	4.6e-05	0.00273	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.58e-05	0.00272	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	4.46e-05	0.00265	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	4.35e-05	0.00258	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	4.3e-05	0.00256	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.3e-05	0.00255	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.3e-05	0.00255	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	4.29e-05	0.00255	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	4.23e-05	0.00251	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.13e-05	0.00245	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—TYK2—systemic lupus erythematosus	4.11e-05	0.00244	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	4.06e-05	0.00241	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	4.03e-05	0.00239	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.96e-05	0.00236	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	3.94e-05	0.00234	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	3.92e-05	0.00233	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.86e-05	0.00229	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.84e-05	0.00228	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.84e-05	0.00228	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.8e-05	0.00225	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.76e-05	0.00223	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	3.74e-05	0.00222	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.74e-05	0.00222	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.55e-05	0.00211	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	3.51e-05	0.00209	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	3.5e-05	0.00208	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	3.44e-05	0.00204	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3.37e-05	0.002	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.37e-05	0.002	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.28e-05	0.00195	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	3.23e-05	0.00192	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.2e-05	0.0019	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	3.17e-05	0.00188	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TNFSF13—systemic lupus erythematosus	3.11e-05	0.00185	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	3.09e-05	0.00183	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	3.08e-05	0.00183	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	3.08e-05	0.00183	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	3.06e-05	0.00182	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SNRPB—systemic lupus erythematosus	3.01e-05	0.00179	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3e-05	0.00178	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.93e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.92e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.91e-05	0.00173	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.84e-05	0.00169	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.79e-05	0.00165	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.74e-05	0.00163	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.74e-05	0.00163	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	2.72e-05	0.00161	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.69e-05	0.0016	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.68e-05	0.00159	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.63e-05	0.00157	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	2.6e-05	0.00154	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.59e-05	0.00154	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.58e-05	0.00153	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.56e-05	0.00152	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.51e-05	0.00149	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.42e-05	0.00144	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2.42e-05	0.00144	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	2.38e-05	0.00142	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	2.23e-05	0.00132	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.22e-05	0.00132	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.19e-05	0.0013	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.08e-05	0.00123	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—systemic lupus erythematosus	2.01e-05	0.00119	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.94e-05	0.00115	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.78e-05	0.00106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TLR9—systemic lupus erythematosus	1.72e-05	0.00102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.71e-05	0.00102	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—JUNB—systemic lupus erythematosus	1.69e-05	0.001	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.66e-05	0.000988	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.63e-05	0.000967	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.57e-05	0.000933	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.54e-05	0.000916	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CSK—systemic lupus erythematosus	1.53e-05	0.000909	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RXRA—systemic lupus erythematosus	1.48e-05	0.00088	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.42e-05	0.000845	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCF2—systemic lupus erythematosus	1.4e-05	0.000832	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LYN—systemic lupus erythematosus	1.39e-05	0.000826	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.36e-05	0.000811	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	1.36e-05	0.000808	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.35e-05	0.000804	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—VDR—systemic lupus erythematosus	1.34e-05	0.000797	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.3e-05	0.000773	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.28e-05	0.000761	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NR3C1—systemic lupus erythematosus	1.21e-05	0.000717	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.18e-05	0.000699	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.12e-05	0.000665	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.1e-05	0.000653	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.1e-05	0.000653	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.09e-05	0.000649	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.09e-05	0.000646	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.08e-05	0.000642	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.04e-05	0.00062	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRL—systemic lupus erythematosus	1.01e-05	0.000601	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.72e-06	0.000578	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—systemic lupus erythematosus	9.35e-06	0.000555	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	8.68e-06	0.000515	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.51e-06	0.000505	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAK1—systemic lupus erythematosus	8.1e-06	0.000481	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR5—systemic lupus erythematosus	7.67e-06	0.000456	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	7.63e-06	0.000453	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.56e-06	0.000449	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—C3—systemic lupus erythematosus	7.5e-06	0.000445	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.39e-06	0.000439	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.08e-06	0.00042	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.9e-06	0.00041	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	6.7e-06	0.000398	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—systemic lupus erythematosus	6.58e-06	0.000391	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD80—systemic lupus erythematosus	6.31e-06	0.000375	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.2e-06	0.000368	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	6.09e-06	0.000362	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.87e-06	0.000349	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.42e-06	0.000322	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TYK2—systemic lupus erythematosus	5.33e-06	0.000316	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—systemic lupus erythematosus	5.23e-06	0.000311	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	4.86e-06	0.000289	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	4.82e-06	0.000286	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.53e-06	0.000269	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.51e-06	0.000268	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—systemic lupus erythematosus	4.43e-06	0.000263	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	4.33e-06	0.000257	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.2e-06	0.000249	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.18e-06	0.000248	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	4.14e-06	0.000246	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—systemic lupus erythematosus	3.98e-06	0.000236	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.85e-06	0.000229	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	3.79e-06	0.000225	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.77e-06	0.000224	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.75e-06	0.000223	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.46e-06	0.000205	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.46e-06	0.000205	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.31e-06	0.000197	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	3.15e-06	0.000187	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.07e-06	0.000182	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.03e-06	0.00018	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.76e-06	0.000164	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.64e-06	0.000157	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—systemic lupus erythematosus	2.61e-06	0.000155	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.52e-06	0.00015	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.42e-06	0.000144	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.37e-06	0.000141	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.13e-06	0.000127	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.04e-06	0.000121	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.01e-06	0.000119	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.86e-06	0.000111	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.55e-06	9.21e-05	CbGpPWpGaD
